Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
Using a lamellar structure as a delivery system, the Sulidin® Nimesulide LPS gel provides enhanced percutaneous penetration of Nimesulide and reduced yellow staining on the skin. LPS Technology worldwide patents are pending. More
25mg dosage strenght for the OTC market in film coated tablets More
Collagen-based biodegradable matrices for localized drug delivery More
25mg dosage strenght for the OTC market More
12,5 mg diclofenac K film coated immediate release tablets (OTC) More
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More
Advatab™ Paracetamol combines 2 of Eurand's proprietary technologies AdvaTab™ and Microcaps® for highly effective taste-masking More
Sodium Diclofenac offered in SR capsules of 75 and 150mg More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
Method of making key intermediates useful in the synthesis of many opiate narcotics and antagonists and agonists; and the non-opiate enantiomers thereof which have potent antitussive properties. More
Displaying 1..10 of 10 - per page
Order by

Your selection

Industry sector
Pharmaceutical del
OTC/Non-Prescription del
Therapeutic target
Central Nervous System del
Pain del

Browse By

Partnering consultation free of charge
Biomarkers for sepsis and infectious diseases
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us